The first Biocryst Pharmaceuticals trade was made in Q4 2015. Since then Joel Greenblatt bought shares eight more times and sold shares on nine occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Biocryst Pharmaceuticals anymore.